Vancomycin De-escalation Therapy in Patients With Pneumonia

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

NCT01561469 ·Status: COMPLETED

Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin

NCT04648696 ·Status: TERMINATED ·Phase: PHASE4

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

NCT01724671 ·Status: UNKNOWN

Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients

NCT01786161 ·Status: TERMINATED ·Phase: PHASE4

Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

NCT01819935 ·Status: COMPLETED

Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus

NCT00175370 ·Status: COMPLETED ·Phase: NA

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

NCT00786305 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

NCT00695903 ·Status: TERMINATED ·Phase: PHASE2

Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation

NCT01925066 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit

NCT05696093 ·Status: RECRUITING ·Phase: PHASE3

Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

NCT00304811 ·Status: COMPLETED ·Phase: PHASE4

Vancomycin Monitoring: Is AUC Monitoring Appropriate for More Than Just Serious MRSA Infections?

NCT05395520 ·Status: UNKNOWN

Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia

NCT01975662 ·Status: TERMINATED ·Phase: PHASE2

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

NCT00572559 ·Status: COMPLETED ·Phase: PHASE4

Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation

NCT05651464 ·Status: UNKNOWN ·Phase: NA

Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis

NCT00324922 ·Status: COMPLETED ·Phase: PHASE3

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

NCT01191840 ·Status: COMPLETED ·Phase: PHASE2

Vancomycin in the Target Site Treatment of Intracranial Infection

NCT03585426 ·Status: UNKNOWN ·Phase: PHASE4

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

NCT00427076 ·Status: COMPLETED ·Phase: PHASE3

Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis

NCT00967941 ·Status: COMPLETED

The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?

NCT01995760 ·Status: COMPLETED

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

NCT00426933 ·Status: COMPLETED ·Phase: PHASE2

Real-world Daptomycin Use in Chinese ICUs

NCT03588637 ·Status: COMPLETED

Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics

NCT01537666 ·Status: COMPLETED ·Phase: PHASE1

Vancomycin Dosage Adjustment for MRSA Infections

NCT03412500 ·Status: UNKNOWN ·Phase: PHASE4